Results of a 2 x 2 Phase III Randomized Trial of Synchronous Chemo-radiotherapy (CRT) Compared to Radiotherapy (RT) Alone and Standard vs. Reduced High Volume RT in Muscle Invasive Bladder Cancer (MIBC) (BC2001 CRUK/01/004)

被引：3
|
作者：
James, N. [1 ]
Hussain, S. [1 ]
Hall, E. [2 ]
Jenkins, P. [3 ]
Tremlett, J. [4 ]
Rawlings, C. [5 ]
Crundwell, M. [6 ]
Waters, R. [2 ]
Huddart, R. A. [2 ]
机构：
[1] Univ Birmingham, Birmingham, W Midlands, England
[2] Inst Canc Res, Sutton, Surrey, England
[3] Cheltenham Gen Hosp, Cheltenham, Glos, England
[4] Brighton & Susgender Univ Hosp NHS Trust, Brighton, E Sussex, England
[5] S Devon Healthcare NHS Fdn, Torquay, England
[6] Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2010年 / 78卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2010.07.048
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S2 / S3
页数：2
相关论文
共 10 条
  • [1] Results of a phase III randomized trial of synchronous chemoradiotherapy (CRT) compared to radiotherapy (RT) alone in muscle-invasive bladder cancer (MIBC) (BC2001 CRUK/01/004)
    James, N. D.
    Hussain, S. A.
    Hall, E.
    Jenkins, P.
    Tremlett, J.
    Rawlings, C.
    Hendron, C.
    Lewis, R.
    Rogers, S.
    Huddart, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Quality of life (QL) of muscle invasive bladder cancer (MIBC) patients (pts) receiving radiotherapy (RT) plus /- chemotherapy (CT) in the BC2001 trial (CRUK/01/004)
    Huddart, R.
    Hall, E.
    Miranda, M.
    Crundwell, M.
    Jenkins, P.
    Rawlings, C.
    Tremlett, J.
    Hendron, C.
    Lewis, R.
    Porta, N.
    Hussain, S.
    James, N.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S186 - S187
  • [3] BC2001 long-term outcomes: A phase III randomized trial of chemoradiotherapy versus radiotherapy (RT) alone and standard RT versus reduced high-dose volume RT in muscle-invasive bladder cancer.
    Hall, Emma
    Hussain, Syed A.
    Porta, Nuria
    Crundwell, Malcolm
    Jenkins, Peter
    Rawlings, Christine Lisa
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [4] Randomized Noninferiority Trial of Reduced High-Dose Volume Versus Standard Volume Radiation Therapy for Muscle-Invasive Bladder Cancer: Results of the BC2001 Trial (CRUK/01/004)
    Huddart, Robert A.
    Hall, Emma
    Hussain, Syed A.
    Jenkins, Peter
    Rawlings, Christine
    Tremlett, Jean
    Crundwell, Malcolm
    Adab, Fawzi A.
    Sheehan, Denise
    Syndikus, Isabel
    Hendron, Carey
    Lewis, Rebecca
    Waters, Rachel
    James, Nicholas D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : 261 - 269
  • [5] BC2001: A multicenter phase III randomized trial of standard versus reduced volume radiotherapy for muscle invasive bladder cancer (ISCRTN:68324339)
    Huddart, R. A.
    James, N. D.
    Adab, F.
    Syndikus, I.
    Jenkins, P.
    Rawlings, C.
    Hendron, C.
    Lewis, R.
    Rogers, S.
    Hall, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] Quality of life (QL) of patients (pts) treated for muscle invasive bladder cancer (MIBC) with radiotherapy (RT) ± chemotherapy (CT) in the BC2001 trial (CRUK/01/004): Analysis of impact of treatment at an individual level.
    Huddart, Robert Anthony
    Hall, Emma
    Miranda, Miguel
    Crundwell, Malcolm
    Jenkins, Peter
    Rawlings, Christine Lisa
    Tremlett, Jean
    Hendron, Carey
    Lewis, Rebecca
    Porta, Nuria
    Hussain, Syed A.
    James, Nicholas D.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [7] Re: Randomized Noninferiority Trial of Reduced High-Dose Volume versus Standard Volume Radiation Therapy for Muscle-Invasive Bladder Cancer: Results of the BC2001 Trial (CRUK/01/004) Editorial Comment
    Huddart, R. A.
    Hall, E.
    Hussain, S. A.
    Jenkins, P.
    Rawlings, C.
    Tremlett, J.
    Crundwell, M.
    Adab, F. A.
    Sheehan, D.
    Syndikus, I.
    Hendron, C.
    Lewis, R.
    Waters, R.
    James, N. D.
    JOURNAL OF UROLOGY, 2014, 191 (06): : 1731 - 1731
  • [8] Updated results of the BC2001 phase III randomized trial of standard vs reduced high dose volume radiotherapy for muscle invasive bladder cancer (ISCRTN:68324339): tumour control, toxicity and quality of life
    Huddart, R.
    James, N. D.
    Adab, F.
    Syndikus, I.
    Jenkins, P.
    Rawlings, C.
    Rogers, S.
    Lewis, R.
    Hendron, C.
    Hussain, S.
    Hall, E.
    EJC SUPPLEMENTS, 2009, 7 (02): : 423 - 423
  • [9] A randomized noninferiority trial of reduced high-dose volume versus standard volume radiation therapy for muscle-invasive bladder cancer: Results of the BC2001 trial (CRUK/01/004) (vol 87, pg 261, 2013)
    Huddart, R. A.
    Hall, E.
    Hussain, S. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (05): : 860 - 860
  • [10] Induction docetaxel platinum 5-FU (TPF) followed by cetuximab-radiotherapy (cetux-RT) versus concurrent chemo-radiotherapy (CT/RT) in patients with N2b/c-N3 non operated stage III-IV squamous cell cancer of the head and neck (SCCHN): Results of the GORTEC 2007-02 phase III randomized trial.
    Geoffrois, Lionnel
    Martin, Laurent
    Garaud, Pascal
    De Raucourt, Dominique
    Miny, Joelle
    Maingon, Philippe
    Lafond, Cedrik
    Tuchais, Claude
    Sire, Christian
    Babin, Emmanuel
    Coutte, Alexandre
    Tao, Yungan
    Rolland, Frederic
    Girard-Calais, Marie Helene
    Bourhis, Jean
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
1